Family · gh
Hexarelin
Examorelin, His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
A synthetic hexapeptide growth hormone secretagogue that binds the ghrelin/GHS receptor (GHS-R1a) to stimulate pulsatile GH release; a potent secretagogue whose GH response can attenuate with repeated dosing (partial, reversible desensitisation).
Human and animal pharmacology studies describe strong GH release and receptor desensitisation; no approved therapeutic indication. Not an approved drug.
- Studied as a GH-secretagogue research probe
- Investigated for cardiovascular signalling in preclinical models
- Used to probe GHS-receptor pharmacology
Educational overview only — no dosing instructions in the public hub.
Receptor desensitisation reduces response over time; can raise cortisol and prolactin; long-term human safety unknown; sourcing/purity is a major practical risk.
Third-party CoA (purity + quantification + MS) is the minimum verification.
Research-use-only; not approved for human use in the EU, UK or US.
Frequently asked questions
- What is Hexarelin used for?
- Studied as a GH-secretagogue research probe. Investigated for cardiovascular signalling in preclinical models. Used to probe GHS-receptor pharmacology. Human and animal pharmacology studies describe strong GH release and receptor desensitisation; no approved therapeutic indication. Not an approved drug.
- Is Hexarelin legal in Europe?
- Research-use-only; not approved for human use in the EU, UK or US.
- What are the risks and side effects of Hexarelin?
- Receptor desensitisation reduces response over time; can raise cortisol and prolactin; long-term human safety unknown; sourcing/purity is a major practical risk.
- How is the quality of Hexarelin assessed?
- Third-party CoA (purity + quantification + MS) is the minimum verification.